Pfizer downgraded by BMO: 'Significant headwinds' will cap the drugmaker's stock run
November 01, 2018 at 08:21 AM EDT
BMO Capital Markets downgraded Pfizer and said shares of the pharmaceutical giant should take a breather from their strong run over the last 12 months.
